C W Boone1, R Lieberman, T Mairinger
1National Cancer Institute, Bethesda, Maryland, USA.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Identifying early prostate cancer changes using nuclear chromatin patterns can validate chemoprevention efficacy. Biomarkers detect subtle alterations, aiding in assessing treatment effectiveness for slow-progressing lesions.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: